The top 8 Healthcare Funds stocks to keep in your portfolio in November 2019

Baron Health Care [BHCUX] is traded in USA and was established 25th of April 2024. Baron Health is listed under Baron Capital Group category by Fama And French industry classification. The fund is listed under Health category and is part of Baron Capital Group family. This fund currently has accumulated 15 M in assets under management (AUM) with minimum initial investment of 5 M. Baron Health Care is currently producing year-to-date (YTD) return of 0.58%, while the total return for the last 3 years was -0.5%.

Biotechnology Fund Class [RYOAX] is traded in USA and was established 25th of April 2024. Biotechnology Fund is listed under Rydex Funds category by Fama And French industry classification. The fund is listed under Health category and is part of Rydex Funds family. This fund at this time has accumulated 117.21 M in assets with no minimum investment requirementsBiotechnology Fund Class is currently producing year-to-date (YTD) return of 0.46%, while the total return for the last 3 years was -5.03%.

Loncar Cancer Immunotherapy [CNCR] is traded in USA and was established 2015-10-13. The fund is listed under Health category and is part of Loncar Investments family. The entity is thematically classified as Robots And Drones. Loncar Cancer Immuno currently have 20.52 M in assets under management (AUM). , while the total return for the last 3 years was -20.1%. At this time, the etf appears to be undervalued. Loncar Cancer Immuno secures a last-minute Real Value of $14.66 per share. The latest price of the etf is $14.23. Our model forecasts the value of Loncar Cancer Immuno from analyzing the etf fundamentals such as Price To Sales of 1.24 X, beta of 0.89, and Price To Earning of 24.63 X as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend buying undervalued stocks and selling overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

IShares [IEIH] is traded in USA and was established 2018-03-21. The fund is listed under Health category and is part of iShares family. IShares currently have 36.3 M in assets under management (AUM). , while the total return for the last 3 years was 13.67%.

Lord Abbett Health [LHCIX] is traded in USA and was established 25th of April 2024. Lord Abbett is listed under Lord Abbett category by Fama And French industry classification. The fund is listed under Health category and is part of Lord Abbett family. This fund now has accumulated 3.27 M in assets with no minimum investment requirementsLord Abbett Health is currently producing year-to-date (YTD) return of 3.54%, while the total return for the last 3 years was -0.86%.

Lord Abbett Health [LHCFX] is traded in USA and was established 25th of April 2024. Lord Abbett is listed under Lord Abbett category by Fama And French industry classification. The fund is listed under Health category and is part of Lord Abbett family. This fund now has accumulated 3.27 M in assets with no minimum investment requirementsLord Abbett Health is currently producing year-to-date (YTD) return of 3.48%, while the total return for the last 3 years was -0.85%.

Eventide Healthcare Life [ETIHX] is traded in USA and was established 25th of April 2024. Eventide Healthcare is listed under Eventide Funds category by Fama And French industry classification. The fund is listed under Health category and is part of Eventide Funds family. This fund currently has accumulated 1.82 B in assets under management (AUM) with minimum initial investment of 100 K. Eventide Healthcare Life is currently producing year-to-date (YTD) return of 4.76%, while the total return for the last 3 years was -8.12%. At this time, the entity appears to be undervalued. Eventide Healthcare Life shows a prevailing Real Value of $34.83 per share. The current price of the fund is $34.06. We determine the value of Eventide Healthcare Life from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.

Allianzgi Health Sciences [HLHIX] is traded in USA and was established 25th of April 2024. Allianzgi Health is listed under Allianz Global Investors category by Fama And French industry classification. The fund is listed under Health category and is part of Allianz Global Investors family. This fund currently has accumulated 175.34 M in assets under management (AUM) with no minimum investment requirementsAllianzgi Health Sciences is currently producing year-to-date (YTD) return of 2.12%, while the total return for the last 3 years was 2.8%.